We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-10.91%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$496M
AUM Growth
-$54.3M
Cap. Flow
+$14.3M
Cap. Flow %
2.89%
Top 10 Hldgs %
37.7%
Holding
138
New
9
Increased
41
Reduced
59
Closed
9

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$9.45M
2
GVA icon
Granite Construction
GVA
+$6.47M
3
BMY icon
Bristol-Myers Squibb
BMY
+$3.74M
4
GSK icon
GSK
GSK
+$3.67M
5
XRAY icon
Dentsply Sirona
XRAY
+$3.06M

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$11.5M
2
IBM icon
IBM
IBM
+$5.1M
3
MRK icon
Merck
MRK
+$3.95M
4
EXC icon
Exelon
EXC
+$3.95M
5
NEE icon
NextEra Energy
NEE
+$3.71M

Sector Composition

Rank Sector Weight
1 Healthcare 26.2%
2 Industrials 23.34%
3 Technology 17.3%
4 Utilities 8.88%
5 Energy 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
101
Cigna
CI
$73.7B
$342K 0.07%
1,800
REGN icon
102
Regeneron Pharmaceuticals
REGN
$78.5B
$336K 0.07%
900
EEM icon
103
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$332K 0.07%
8,500
-400
-4% -$16K
CELG
104
DELISTED
Celgene Corp
CELG
$321K 0.06%
5,008
-600
-11% -$44.3K
GM icon
105
General Motors
GM
$80.4B
$319K 0.06%
9,550
-200
-2% -$6.9K
AGCO icon
106
AGCO
AGCO
$7.15B
$301K 0.06%
+5,400
New +$305K
SHW icon
107
Sherwin-Williams
SHW
$82.7B
$288K 0.06%
2,193
EXC icon
108
Exelon
EXC
$47.2B
$282K 0.06%
8,763
-123,460
-93% -$3.95M
MU icon
109
Micron Technology
MU
$930B
$276K 0.06%
8,685
-15
-0.2% -$569
MCD icon
110
McDonald's
MCD
$192B
$267K 0.05%
1,505
-65
-4% -$11.5K
VZ icon
111
Verizon
VZ
$195B
$264K 0.05%
4,703
+75
+2% +$4.26K
HOLX
112
DELISTED
Hologic
HOLX
$259K 0.05%
6,300
+100
+2% +$4.1K
ST icon
113
Sensata Technologies
ST
$6.74B
$256K 0.05%
5,700
ON icon
114
ON Semiconductor
ON
$31.8B
$251K 0.05%
15,200
+3,100
+26% +$53.6K
QQQ icon
115
Invesco QQQ Trust
QQQ
$453B
$251K 0.05%
1,624
CHL
116
DELISTED
China Mobile Limited
CHL
$250K 0.05%
5,200
PAYX icon
117
Paychex
PAYX
$41.6B
$249K 0.05%
3,825
-87
-2% -$5.89K
COHR icon
118
Coherent
COHR
$51.4B
$237K 0.05%
7,300
+300
+4% +$11.2K
ITW icon
119
Illinois Tool Works
ITW
$82.6B
$228K 0.05%
1,800
-501
-22% -$66K
CRUS icon
120
Cirrus Logic
CRUS
$6.53B
$216K 0.04%
+6,500
New +$241K
GILD icon
121
Gilead Sciences
GILD
$162B
$213K 0.04%
3,400
+200
+6% +$14K
PLOW icon
122
Douglas Dynamics
PLOW
$1.02B
$201K 0.04%
5,600
TEO icon
123
Telecom Argentina
TEO
$6.03B
$179K 0.04%
11,500
FAN icon
124
First Trust Global Wind Energy ETF
FAN
$278M
$174K 0.04%
15,200
-800
-5% -$9.38K
FNB icon
125
FNB Corp
FNB
$6.73B
$156K 0.03%
+15,857
New +$184K

Similar funds

John G. Ullman & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, John G. Ullman & Associates held 138 positions worth $496M, down 9.9% from $550M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

John G. Ullman & Associates's Q4 2018 filing shows 9 new, 41 increased, 59 reduced and 9 closed positions. Its largest new stake was Astec Industries: 74,600 shares worth $2.25M. The largest sale was SLB Ltd, an estimated $11.5M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2018 buy was Astec Industries: 74,600 shares worth $2.25M.
  • John G. Ullman & Associates added most to Emerson Electric in Q4 2018, an estimated $9.45M increase.
  • John G. Ullman & Associates's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $11.5M.
  • John G. Ullman & Associates fully exited Swiss Helvetia Fund in Q4 2018, selling an estimated $2.51M.
  • John G. Ullman & Associates's ten largest holdings make up 38% of its $496M portfolio in Q4 2018.
  • John G. Ullman & Associates opened 9 new positions and closed 9 in Q4 2018.
  • John G. Ullman & Associates's portfolio value fell 9.9% quarter-over-quarter to $496M.

Based on John G. Ullman & Associates's 13F filing for Q4 2018, filed 29 Jan 2019.